This site provides INTERCEPT product information for Health Care Professionals in the United States.

Cerus Webinars

Hemostatic Efficacy of Pathogen Reduced Platelets in Pediatric Cardiopulmonary Bypass

Runtime: 20 min

Leading US hospitals1 are implementing PR platelets to ensure platelet availability and safety across a broad spectrum of pathogens. Doctor Marianne Nellis of Cornell shares study findings that assess PR platelet hemostatic efficacy via bleeding in pediatric patients.

Presented by:

Marianne E. Nellis, MD, MS
Pediatrician/Attending Physician
Division of Pediatric Critical Care Medicine
Department of Pediatrics
Weill Cornell Medicine

  1. U.S. News & World Report Hospital Rankings & Ratings, 2020-2021,